ADC Therapeutics SA, of Lausanne, Switzerland, appointed Joseph Camardo head of medical affairs.
Affimed NV, of Heidelberg, Germany, appointed Andreas Harstrick chief medical officer, effective March 2020.
Aravive Inc., of Houston, appointed Rekha Hemrajani president, CEO and director and Jay Shepard chair of its board.
Aspen Neuroscience Inc., of San Diego, appointed Kim P. Kamdar, David L. Barker, Howard J. Federoff, Erich Mohr and Stephen Squinto to its board. It also appointed Roger Barker, Kapil Bharti, David Eidelberg, Jane S. Lebkowski and Jeremy Sugarman to its scientific advisory board.
Candel Therapeutics Inc., of Needham, Mass., appointed Sandra E. Poole chief operating officer.
Diffusion Pharmaceuticals Inc., of Charlottesville, Va., appointed Robert Cobuzzi Jr. to its board.
Glauconix Biosciences Inc., of Albany, N.Y., appointed Kim Southern CEO and to its board.
Impel Neuropharma Inc., of Seattle, appointed Adrian Adams chair of its board.
Passage Bio, of Philadelphia, appointed Sandip Kapadia to its board.
Rockwell Medical Inc., of Wixom, Mich., appointed Russell H. Ellison to its board.
Selexis SA, of Geneva, appointed Yemi Onakunle chief business officer.
Tauc3 Biologics Ltd., of London, appointed Andrew J. Heath non-executive chair of its board and Shafique Virani non-executive director.